Evidence map›Paper›PMID 34790517›Full record

ArticleClinical nephrology. Case studies2021

Bile acid nephropathy induced by anabolic steroids: A case report and review of the literature.

Hamdan Al Awadhi, Sarah Al Qassimi, Aya Akhras, Leal Herlitz, Muriel Ghosn

Open access · greenAbstract read
In one paragraph

Article in Clinical nephrology. Case studies, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hamdan Al AwadhiDivision of Internal Medicine, Department of Medicine, Cleveland Clinic Abu Dhabi Hospital, Abu Dhabi, UAE.
Sarah Al QassimiDivision of Internal Medicine, Department of Medicine, Cleveland Clinic Abu Dhabi Hospital, Abu Dhabi, UAE.
Aya AkhrasDivision of Internal Medicine, Department of Medicine, Cleveland Clinic Abu Dhabi Hospital, Abu Dhabi, UAE.
Leal HerlitzDepartment of Pathology, Cleveland Clinic, Cleveland, Ohio, USA, and.
Muriel GhosnDivision of Nephrology, Department of Medicine, Cleveland Clinic Abu Dhabi Hospital, Abu Dhabi, UAE.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bile acid nephropathy also known as cholemic nephropathy is a rare and overlooked form of acute kidney injury that occurs in the setting of severe hyperbilirubinemia. The exact etiology remains unknown, and there is a lack of treatment guidelines for this clinical condition. Anabolic steroids are known to cause hepatoxicity occasionally leading to acute kidney injury. We report the case of a 27-year-old male patient who developed bile acid nephropathy as a result of severe hyperbilirubinemia secondary to anabolic steroids-induced liver injury. He was conservatively managed. We review the current literature touching on the etiology, pathophysiology, diagnosis, and management of bile acid nephropathy in an attempt to shed light on this clinical condition, which may present as a diagnostic and therapeutic challenge.

Indexed as

anabolic steroidsbile acid nephropathycholemic nephropathydrug-induced liver injury

Identifiers

PMID34790517
PMCPMC8594315
OpenAlexW3213461887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.